files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346

References

  1. Rana, J.S., A. Dunning, S. Achenbach, M. Al-Mallah and M.J. Budoff et al., 2012. Differences in Prevalence, Extent, Severity, and Prognosis of Coronary Artery Disease Among Patients With and Without Diabetes Undergoing Coronary Computed Tomography Angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes): an InteRnational Multicenter Registry. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Diabetes Care, 35: 1-10.
  2. Capes, S.E., D. Hunt, K. Malmberg and H.C. Gerstein, 2000. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The Lancet, 355: 1-10.
  3. Ishihara, M., S. Kojima, T. Sakamoto, Y. Asada and C. Tei et al., 2005. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Am. Heart J., 150: 1-10.
  4. Kassaian, S.E., H. Goodarzynejad, M.A. Boroumand, M. Salarifar and F. Masoudkabir et al., 2012. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Cardiovasc. Diabetology, Vol. 11. 10.1186/1475-2840-11-82 1-10.
  5. Cuisset, T., B. Gaborit, N. Dubois, J. Quilici and M. Loosveld et al., 2013. Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Cardiol., 168: 1-10.
  6. Bornfeldt, K.E. and I. Tabas, 2011. Insulin Resistance, Hyperglycemia, and Atherosclerosis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Cell Metab., 14: 1-10.
  7. Shoukat, S., S.A. Gowani, A. Jafferani and S.H. Dhakam, 2010. Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Cardiol. Res. Pract., Vol. 2010. 10.4061/2010/649164 1-10.
  8. Abdel-Ghany, M., G. Morsy and Y.T. Kishk, 2021. Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The Egypt. J. Internal Med., Vol. 33. 10.1186/s43162-021-00043-2 1-10.
  9. Haffner, S.M., S. Lehto, T. Rönnemaa, K. Pyörälä and M. Laakso, 1998. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New Engl. J. Med., 339: 229-234.
  10. Malmberg, K., S. Yusuf, H.C. Gerstein, J. Brown and F. Zhao et al., 2000. Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Circulation, 102: 1-10.
  11. Ertelt, K., S.J. Brener, R. Mehran, O. Ben-Yehuda, T. McAndrew and G.W. Stone, 2017. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study). 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, The Am. J. Cardiol., 119: 1-10.
  12. Yuan, J. and G.M. Xu, 2018. Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Am. J. Cardiovasc. Drugs, 18: 1-10.